These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 22212015)
1. Mucocutaneous manifestations of HIV-infected patients in the era of HAART in Guangxi Zhuang Autonomous Region, China. Han J; Lun WH; Meng ZH; Huang K; Mao Y; Zhu W; Lian S J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):376-82. PubMed ID: 22212015 [TBL] [Abstract][Full Text] [Related]
2. Spectrum of skin disorders in human immunodeficiency virus-infected patients in Singapore and the relationship to CD4 lymphocyte counts. Goh BK; Chan RK; Sen P; Theng CT; Tan HH; Wu YJ; Paton NI Int J Dermatol; 2007 Jul; 46(7):695-9. PubMed ID: 17614796 [TBL] [Abstract][Full Text] [Related]
3. Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades. Seoane Reula E; Bellon JM; Gurbindo D; Muñoz-Fernandez MA Br J Dermatol; 2005 Aug; 153(2):382-9. PubMed ID: 16086754 [TBL] [Abstract][Full Text] [Related]
4. Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China. Zhang L; Huang Y; Liu Z; Liu W; Qin Q; Tao R J Med Virol; 2015 Jul; 87(7):1158-67. PubMed ID: 25777553 [TBL] [Abstract][Full Text] [Related]
5. Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression. Nnoruka EN; Chukwuka JC; Anisuiba B Int J Dermatol; 2007 Oct; 46 Suppl 2():14-8. PubMed ID: 17958624 [TBL] [Abstract][Full Text] [Related]
6. Effects of CD4 cell count and antiretroviral therapy on mucocutaneous manifestations among HIV/AIDS patients in Yunnan, China. Li YY; Yang SH; Wang RR; Tang JT; Wang HM; Kuang YQ Int J Dermatol; 2020 Mar; 59(3):308-313. PubMed ID: 31846069 [TBL] [Abstract][Full Text] [Related]
7. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy. Wong KH; Chan KC; Lee SS Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819 [TBL] [Abstract][Full Text] [Related]
8. The prevalence of HIV associated oral lesions among adults in the era of HAART. Mthethwa SR; Wanjau J; Chabikuli N SADJ; 2013 Sep; 68(8):364-71. PubMed ID: 24660404 [TBL] [Abstract][Full Text] [Related]
9. Skin manifestation of Thai HIV infected patients in HAART era. Punyaratabandhu P; Prasithsirikul W; Jirachanakul P J Med Assoc Thai; 2012 Apr; 95(4):497-504. PubMed ID: 22612002 [TBL] [Abstract][Full Text] [Related]
10. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients. Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940 [TBL] [Abstract][Full Text] [Related]
11. Patterns of skin manifestations and their relationships with CD4 counts among HIV/AIDS patients in Cameroon. Josephine M; Issac E; George A; Ngole M; Albert SE Int J Dermatol; 2006 Mar; 45(3):280-4. PubMed ID: 16533229 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India. Shah SU; Kerkar SP; Pazare AR Br J Ophthalmol; 2009 Jan; 93(1):88-90. PubMed ID: 18952644 [TBL] [Abstract][Full Text] [Related]
13. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829 [TBL] [Abstract][Full Text] [Related]
14. Histopathological study of pruritic papular eruptions in HIV-infected patients in relationship with CD4, CD8 counts. Annam V; Yelikar BR; Inamadar AC; Palit A Indian J Pathol Microbiol; 2009; 52(3):321-4. PubMed ID: 19679951 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of skin disease in patients infected with human immunodeficiency virus in Bangkok, Thailand. Sivayathorn A; Srihra B; Leesanguankul W Ann Acad Med Singap; 1995 Jul; 24(4):528-33. PubMed ID: 8849182 [TBL] [Abstract][Full Text] [Related]
16. [Safety study of 52-week highly active antiretroviral therapy in 198 HIV/AIDS Chinese patients]. Li WJ; Dai Y; Han Y; Qiu ZF; Xie J; Zuo LY; Li YL; Li TS Zhonghua Yi Xue Za Zhi; 2011 May; 91(19):1318-22. PubMed ID: 21756757 [TBL] [Abstract][Full Text] [Related]
17. Mucocutaneous manifestations in human immunodeficiency virus (HIV)-infected patients in Nouakchott, Mauritania. Boushab BM; Malick Fall FZ; Ould Cheikh Mohamed Vadel TK; Ould Cheikh Melaïnine ML; Maazouz MV; Savadogo M; Basco LK Int J Dermatol; 2017 Dec; 56(12):1421-1424. PubMed ID: 28960268 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of dyslipidemia among human immunodeficiency virus infected Nigerians. Muhammad S; Sani MU; Okeahialam BN Ann Afr Med; 2013; 12(1):24-8. PubMed ID: 23480991 [TBL] [Abstract][Full Text] [Related]
19. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients. Ho C; Lee S; Wong Kh; Cheng L; Lam M HIV Med; 2007 Apr; 8(3):181-5. PubMed ID: 17461862 [TBL] [Abstract][Full Text] [Related]
20. Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience. Zancanaro PC; McGirt LY; Mamelak AJ; Nguyen RH; Martins CR J Am Acad Dermatol; 2006 Apr; 54(4):581-8. PubMed ID: 16546578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]